Literature DB >> 18950889

Analysis of factors influencing pancreatic beta-cell function in Japanese patients with type 2 diabetes: association with body mass index and duration of diabetic exposure.

Shogo Funakoshi1, Shimpei Fujimoto, Akihiro Hamasaki, Hideya Fujiwara, Yoshihito Fujita, Kaori Ikeda, Yoshiyuki Hamamoto, Masaya Hosokawa, Yutaka Seino, Nobuya Inagaki.   

Abstract

AIMS: To elucidate the clinical factors affecting beta-cell function, serum C-peptide immunoreactivity (CPR) levels of patients with type 2 diabetes were analyzed.
METHODS: Seven hundred Japanese patients with type 2 diabetes were enrolled. beta-Cell function was evaluated by fasting CPR (FCPR), 6 min after intravenous injection of 1mg glucagon (CPR-6 min), and the increment of CPR (DeltaCPR). Simple regression analysis between FCPR, CPR-6 min, and DeltaCPR and measures of variables and stepwise multiple regression analysis were carried out.
RESULTS: Years from diagnosis and BMI were the major independent variables predicting beta-cell function. Years from diagnosis was negatively correlated with CPR-6 min (P<0.0001, r=-0.271), and decrease in CPR-6 min was 0.050 ng/(ml year). BMI was positively correlated with CPR-6 min (P<0.0001, r=0.369). When subjects were divided according to BMI, the decrease in CPR-6 min per year in the high-BMI group (0.068 ng/(ml year)) was greater than that in the low-BMI group (0.035 ng/(ml year)).
CONCLUSION: A linear decline in endogenous insulin secretion over more than several decades of diabetes was confirmed by this cross-sectional study. The duration of diabetes exposure and BMI are thus major factors in beta-cell function in Japanese patients with type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18950889     DOI: 10.1016/j.diabres.2008.09.010

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  38 in total

Review 1.  β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes.

Authors:  Yoshifumi Saisho
Journal:  World J Diabetes       Date:  2015-02-15

2.  Association between BMI and risk of severe hypoglycaemia in type 2 diabetes.

Authors:  J-S Yun; Y-M Park; K Han; S-A Cha; Y-B Ahn; S-H Ko
Journal:  Diabetes Metab       Date:  2018-04-06       Impact factor: 6.041

3.  miR-375 enhances palmitate-induced lipoapoptosis in insulin-secreting NIT-1 cells by repressing myotrophin (V1) protein expression.

Authors:  Yan Li; Xuejuan Xu; Ying Liang; Shanying Liu; Huisheng Xiao; Feng Li; Hua Cheng; Zuzhi Fu
Journal:  Int J Clin Exp Pathol       Date:  2010-01-25

4.  20/(fasting C-peptide × fasting plasma glucose) is a simple and effective index of insulin resistance in patients with type 2 diabetes mellitus: a preliminary report.

Authors:  Tsuyoshi Ohkura; Hideki Shiochi; Youhei Fujioka; Keisuke Sumi; Naoya Yamamoto; Kazuhiko Matsuzawa; Shoichiro Izawa; Hiroshi Kinoshita; Hiroko Ohkura; Masahiko Kato; Shin-ichi Taniguchi; Kazuhiro Yamamoto
Journal:  Cardiovasc Diabetol       Date:  2013-01-22       Impact factor: 9.951

5.  Associations between hemoglobin concentrations and the clinical characteristics of patients with type 2 diabetes.

Authors:  Jin Ook Chung; Dong Hyeok Cho; Dong Jin Chung; Min Young Chung
Journal:  Korean J Intern Med       Date:  2012-09-01       Impact factor: 2.884

6.  Associations among body mass index, insulin resistance, and pancreatic β-cell function in Korean patients with new-onset type 2 diabetes.

Authors:  Jin Ook Chung; Dong Hyeok Cho; Dong Jin Chung; Min Young Chung
Journal:  Korean J Intern Med       Date:  2012-02-28       Impact factor: 2.884

7.  Clinical characteristics and beta cell function in Chinese patients with newly diagnosed type 2 diabetes mellitus with different levels of serum triglyceride.

Authors:  Shuang Zheng; Huan Zhou; Tingting Han; Yangxue Li; Yao Zhang; Wei Liu; Yaomin Hu
Journal:  BMC Endocr Disord       Date:  2015-04-29       Impact factor: 2.763

8.  Impact of triglycerides and waist circumference on insulin resistance and β-cell function in non-diabetic first-degree relatives of type 2 diabetes.

Authors:  Fahd Ahmed; Molham Al-Habori; Ebtesam Al-Zabedi; Riyadh Saif-Ali
Journal:  BMC Endocr Disord       Date:  2021-06-16       Impact factor: 2.763

9.  Sitagliptin versus mitiglinide switched from mealtime dosing of a rapid-acting insulin analog in patients with type 2 diabetes: a randomized, parallel-group study.

Authors:  Yumie Takeshita; Toshinari Takamura; Yuki Kita; Akiko Takazakura; Ken-Ichiro Kato; Yuki Isobe; Shuichi Kaneko
Journal:  BMJ Open Diabetes Res Care       Date:  2015-08-28

10.  Teneligliptin, a Dipeptidyl Peptidase-4 Inhibitor, Improves Early-Phase Insulin Secretion in Drug-Naïve Patients with Type 2 Diabetes.

Authors:  Rika Ito; Tomoyasu Fukui; Toshiyuki Hayashi; Anna Osamura; Makoto Ohara; Noriko Hara; Akiko Higuchi; Takeshi Yamamoto; Tsutomu Hirano
Journal:  Drugs R D       Date:  2015-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.